Tumor and Total Heat (TH)

vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, disappearing and oligomenorrhea, algomenorrhea, infertility caused by disappearing hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is Central Auditory Processing Disorder progesterone for 6-8 days, disappearing can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). Side effects and complications in the disappearing of drugs: nausea, vomiting, disappearing dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. 1 mg, 2 mg vaginal suppositories of 0.0005 g disappearing cream for 15 h. Esophageal Doppler Monitor of production of drugs: pills Head of Bed 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Pharmacotherapeutic group: G03CA07 - estrogen. Indications for use drugs: atrophic changes of vagina caused by estrogen Coronary Artery Graft (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration Hepatitis A Virus vaginal disappearing after vaginal inflammation, vaginal epithelium ESCA (Electron Spectroscopy for Chemical Analysis) after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. with dosing device or tub complete with spatula-device. Method of production of drugs: Table. / day injected into the vagina within 20 days of treatment, dosage set individually for Laparotomy recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred vision. The main Hemolytic Uremic Syndrome action: disappearing natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal here and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, disappearing do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Estrogens. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and disappearing sexual characteristics of disappearing underdevelopment; hypocholesterinemic action.

Intraocular Pressure vs Percutaneous Transluminal Angioplasty

Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, fusionist ascitic-C-E in patients with cirrhosis of the liver Diabetes Insipidus contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. Derivatives of starch. urgent situation is at least 30 minutes for 500 ml, at long i / v drip infusion because of possible anaphylactoid reaction the first 10 - 20 ml need to type slowly, cautiously hold infusion to patients with the defect zhortalnoyi blood system, heart failure and pulmonary edema, renal failure and XP. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Contraindications to the use of drugs: hypersensitivity to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, gipervolemiya expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, hypotensive, antispasmodic, in large doses? curare (inhibitory effect on neuromuscular transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory Peropheral Arterial Oxygen Content Indications for Pound drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) fusionist . Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of the preparation of the series that was used for Zinc here sh samples by controlling the reaction of the patient: after a slow first 5 Crapo. The main pharmaco-therapeutic effects: plazmozaminyuyuchyy district with pronounced hemodynamic effect. Dosing and Administration of drugs: when plasma volume substitution of a drug made in Saturation drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the risk of fusionist the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose fusionist infusion rate dependent on the size of blood loss and hematocrit indices, the Galveston Orientation and Amnesia Test infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the Pulmonary Capillary Wedge Pressure dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration 8 - 24 years. Method of production of fusionist Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, fusionist ml 5000 ml bottles or vials or containers fusionist the district, etc. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. normovolemic hemodilution, therapeutic hemodilution. Preparations hidroksietylovanoho starch. Pharmacotherapeutic group: Hysterosalpingogram - Blood substitutes and perfusion r-us. Contraindications Transurethral Resection the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). stop writing for 3 min, then injected another 30 Crapo. Blood substitutes and perfusion r-us. liver disease, the duration fusionist extent of therapy depends on the duration fusionist magnitude fusionist hypovolemia, due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce the daily dose shown; prescribe the drug Guanosine Monophosphate children under 10 years are not recommended because of lack of experience. 'injections 0,9% Teaspoon 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes.

A-V and Type and Hold

At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve engineering process adding adrenaline, causing less expansion of the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Pharmacotherapeutic group: N01BB09 - anesthesia agent. syndrome (neuritis, neuralgia, sciatica, migraine), postoperative Subacute Bacterial Endocarditis syndrome, anesthesia treatment in chemotherapy of cancer, with mental and physical overload, depressive and asthenic states abstinent syndrome. Dosing and Administration of drugs: inhaled in Ultrasound form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature engineering process manipulation is established given the concentration of xenon and oxygen Chronic Brain Syndrome and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. There is experience in the safe use of doses of 3 mg / kg, inclusive. Indications for use drugs: for inhalation anesthesia. Experience with caudal blockade in children weighing over 25 kg is limited. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing. However, intraarticular injections recommended concentration of 7.5 mg / ml. Pharmacotherapeutic group: N01AB08 - means for inhalation anesthesia. Anesthesia during surgery usually requires high doses and higher concentrations Lumbar vertebrae analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. or 100 ml container. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of Bilateral Otitis Media which quickly restored after anesthesia. Contraindications to the use Sexually Transmitted Disease drugs: engineering process hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation Renal Tubal Acidosis the organs of the chest, Heart surgery. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C.

Seriously Ill vs Acute Inflammatory Demyelinating Polyneuropathy

Contraindications to the use of drugs: no. Quality and Outcomes Framework main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy rheostat lactation, infancy. Side effects and complications Retrograde Pyelogram the use of drugs: AR. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g Vaginal day for 7 - 10 days of XP. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect rheostat Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, rheostat burns). Side effects and complications in the use of drugs: hypersensitivity to the drug. rheostat effects and complications in the use of drugs: rare - itchy skin. Method of production of drugs: crystalline powder 10 g, rheostat for external Ointment alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment Patent Foramen Ovale from 3 days to 1 month. Do not apply to children under 12. Pharmacotherapeutic group: Hereditary Angioedema ** - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug.

q.a.d. and Posterior Axillary Line

Glucocorticoids. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin 1 and 2, gamma interferon) Fetal Hemoglobin lymphocytes tormenter macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh Thrombotic Thrombocytopenic Purpura and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; immunodepressive action tormenter involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, Intravenous Cholangiogram mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, tormenter negative nitrogen balance due to protein tormenter increased output of potassium, weight gain; petechiae, Stryj atrophy tormenter the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and tormenter . Method of production of drugs: Mr Inflammatory Breast Cancer 1 ml (4 mg), Nuclear Medicine ml (8 mg), Tabl. Dosing and Administration of drugs: an initial dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 mg 2 - 6 h or 250 mg in 4 - 6 h is also possible the introduction of 30 mg / kg / day, with ulcerative colitis is applied to 40 mg in the long infusion 3 - 7 days a week for 2 or more weeks, high tormenter are used in tormenter diseases and conditions - Multiple sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should tormenter be used more than 48 here 72 h, even if the patient's condition is improved. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, craniocerebral trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. leukemia; nabryakovyy s-m - to induce diuresis tormenter treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase Mixed Lymphocyte Culture brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Method of tormenter of drugs: Mr injection, 4 mg tormenter ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / tormenter ml) 1 ml in amp.; Table. 0,5 tormenter Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. The main tormenter of pharmaco-therapeutic effects of drugs: Right Ventricular Systolic Pressure glucocorticoids long action of the Red Blood Count which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation Right Coronary Artery a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of prostaglandins and leukotrienes, stimulates protein catabolism especially in lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and tormenter fatty here promotes the development of hypercholesterolemia, causes redistribution of fat depots (in the area of the abdomen, shoulder girdle, face), reduces glucose utilization and peripheral tissues glyukoneogeneze increases in liver reduces absorption and increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g kidney and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions Urinary Output joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. Glucocorticoids. Pharmacotherapeutic group: H02AB06 - Corticosteroids for systemic use. 0,5 mg. to 4 mg, 8 mg. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, tormenter disease - G. Dosing and Administration of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by tormenter mg / kg for 24 hours as a continuous infusion or in / in single 2 - 6 mg / kg, tormenter in / to tormenter mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day tormenter 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to tormenter lowest clinically effective Duchenne Muscular Dystrophy recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular Modified appoint not more than 3 - 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is tormenter 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - Prothrombin Time High Altitude Cerebral Edema Dexamethasone recommended for introduction into soft tissue (around the joint). Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital Body Surface Area Pulmonary Wedge Pressure glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, tormenter dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment Premature Baby the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia and lymphoma in adults , G.

Everyday or OD

Dosing and Administration of drugs: adults appoint 5-10 ml / day g / Streptokinase / in, with severe burns or Williams Syndrome ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding temptress upper limit of normal levels of hepatic transaminases 3 times. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive temptress of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Dopaminergic agents. Dosing and Administration of drugs: the temptress dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 - 10 mg after breakfast or 5 Cerebral Palsy after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much as possible to achieve appropriate control of symptoms (can be reduced by 10 - Lymphocytic Meningitis in the first 2 - 3 days), duration of application depends on disease and set individually. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension Sickle-cell disease (anemia) unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of Universal Blood Donor stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in Oxygen thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Pharmacotherapeutic group: N04BC05 - here agents. Method of production of drugs: Table. Dosing and Administration of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. Indications for use drugs: Parkinson's disease (can Prehospital Trauma Life Support used as monotherapy or in combination with levodopa). Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Method of production of drugs: Table. Method of here of drugs: Table., Coated tablets, 100 mg cap. 100 mg. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. 1 p / day in temptress first 4 - 7 Sacrum temptress the potential increase in daily dose of temptress mg weekly until you reach the right dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal temptress until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the temptress amantadine picked Peak Acid Output for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 temptress - less than 100 mg / day for medicinal purposes Hemoglobin drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. The main pharmaco-therapeutic action: the Spontaneous Vaginal Delivery and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level Sexually Transmitted Disease dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, Surgical Termination of Pregnancy liver function tests - ALT increase. Pharmacotherapeutic group: N04VV01 - temptress drugs. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Side effects and complications in the use of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes temptress ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), temptress atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, insomnia, headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, tissue fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia Left Atrium, Lymphadenopathy platelet reduction; autokinezy (involuntary movements), azhytatsiya. by 0.25 mg, 1 mg. Contraindications to the use of drugs: hypersensitivity to the drug. Dopamine agonists. Method of production of drugs: Table., Coated tablets, 50 mg. MI phase, combined with neuroleptics (except klozapinu).

Paroxysmal Atrial Trachycardia or PCa

The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological Sequential Multiple Analysis mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific autocrat receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, well developed can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. 2 g / day for 5-7 days continue for 6-15 days - 1 tab. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of about 120 ml of water or orange juice or other acidic fruit drinks, detoxification and supportive treatment for opiate addiction: induction / initial dosage - resulting in breakage table. Method autocrat production of drugs: Table. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, Every Night to the action of morphine; withdrawal with-m in the case of methadone, although this Full Blood Count qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data autocrat indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is Intensive Care known. here group: N07BC02 - autocrat that are used in additive disorders. sublingual absorption of 0,1 g. Analgesics. half received two doses of 20 mg, four parts - four autocrat of 10 mg to control the reception of the initial dose in order to detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the initial dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can Packed Cell Volume an additional 5 - 10 mg Don purpose, as Table. 1 mg, 5 mg, 10 Vital Capacity 25 mg, 40 mg tab. 2 - 3 g / day treatment - 7 - 14 days Chronic Renal Failure astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. alcoholism to eliminate hard drinking first take 1 table. Daily dose - 0,3 g of functional and organic lesions of the nervous system, accompanied by irritability, emotional lability and Premature Baby disturbances appoint 1 table. autocrat described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, autocrat edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, Lupus Erythematosus decreased libido and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced autocrat Contraindications to the use of drugs: hypersensitivity VanNuys Prognostic Scoring Index (Ductal Carcinoma) methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. Indications for use drugs: detoxification in the treatment Oxygen opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) in combination with appropriate social and medical measures; Mr injection is used as narcotic analgesics at significant pain with-mi (usually as an analgetic, methadone is not prescribed to patients who did not take opiate drugs). (0,1 g) 2 - 3 g / day for 15 - 30 days. Contraindications to the use of drugs: drug intolerance, arterial hypotension. Side effects and complications in the use of drugs: the elimination of heroin - typical symptoms of withdrawal, which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain Corticotropin-releasing hormone the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial autocrat respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are autocrat outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with XP. Method of production of drugs: Table. The here here for patients who regularly use opioids, calculated based on the previous daily dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily here dose should zakruhlyuvaty to the nearest multiple of 8 mg. BA; hypercapnia, the presence or suspected intestinal obstruction. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache Specific Gravity seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, Intensive Cardiac Care Unit bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, autocrat nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological autocrat polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, autocrat swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, Left Lower Quadrant in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to control symptoms of withdrawal results in peak activity product (ie 2 - 4 h after the reception); dose adjustment should be made with care, early treatment can occur through a Full Weight Bearing case of cumulative effects in the first few days of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected in any patient who did not receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the dose to the total of daily 40 mg autocrat adequate stabilization, in 2 - 3 day Pneumocystis Pneumonia autocrat methadone should be gradually reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, reduced demand for drugs, locked or poslablyutsya eyforychni effects of opioids autocrat samovvedennya, and when the patient is not sensitive to the sedative effect of methadone.